Skip to main content

Rolvedon Injection Dosage

Generic name: EFLAPEGRASTIM 13.2mg in 0.6mL
Dosage form: injection, solution
Drug class: Colony stimulating factors

Medically reviewed by Last updated on Nov 8, 2023.

Recommended Dosage

The recommended dosage of Rolvedon is a single subcutaneous injection of 13.2 mg administered once per chemotherapy cycle. Administer approximately 24 hours after cytotoxic chemotherapy. Do not administer within the period from 14 days before to 24 hours after administration of cytotoxic chemotherapy.


‚ÄčRolvedon is administered subcutaneously via a single-dose prefilled syringe.

Prior to use‚ take the carton out of the refrigerator and place the sealed blister tray on a clean flat surface for a minimum of 30 minutes to allow the product to reach room temperature. Do not warm up the prefilled syringe in any other way. Discard any prefilled syringe left at room temperature for greater than 12 hours. Do not shake. If Rolvedon is accidentally frozen, do not use. Remove the tray from box and carefully remove the prefilled syringe from the tray. If you drop the prefilled syringe onto a hard surface, do not use it. Use a new syringe for the injection.

Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit. Do not administer Rolvedon if discoloration or particulates are observed.

Administer the entire contents of the prefilled syringe.

If the patient or caregiver misses a dose of Rolvedon, instruct them to contact their healthcare provider.

The Rolvedon prefilled syringe does not bear graduation marks and is intended only to deliver the entire contents of the syringe (13.2 mg/0.6 mL) for direct administration.

Not made with natural rubber latex.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.